BNP Paribas Financial Markets’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$38.5M Buy
544,961
+248,888
+84% +$13.4M 0.01% 888
2026
Q1
$15.5M Buy
296,073
+10,922
+4% +$656K 0.01% 1322
2025
Q4
$16.8M Buy
285,151
+34,255
+14% +$2.08M 0.01% 1290
2025
Q3
$14M Sell
250,896
-166,664
-40% -$8.93M 0.01% 1329
2025
Q2
$21.5M Buy
417,560
+58,937
+16% +$2.96M 0.01% 1003
2025
Q1
$21M Buy
358,623
+76,876
+27% +$5.21M 0.01% 1020
2024
Q4
$20.3M Buy
281,747
+107,667
+62% +$7.91M 0.01% 1017
2024
Q3
$13.9M Sell
174,080
-52,235
-23% -$3.93M 0.01% 1022
2024
Q2
$16.2M Buy
226,315
+10,141
+5% +$746K 0.01% 875
2024
Q1
$15.2M Buy
216,174
+73,453
+51% +$5.26M 0.01% 896
2023
Q4
$11M Buy
142,721
+36,590
+34% +$2.41M 0.01% 984
2023
Q3
$7.22M Sell
106,131
-10,772
-9% -$851K 0.01% 1053
2023
Q2
$9.54M Sell
116,903
-24,143
-17% -$1.94M 0.01% 935
2023
Q1
$10.5M Buy
141,046
+66,187
+88% +$5.1M 0.01% 877
2022
Q4
$6.2M Sell
74,859
-160,569
-68% -$12.8M 0.01% 1204
2022
Q3
$16.7M Buy
235,428
+111,956
+91% +$9.67M 0.03% 714
2022
Q2
$10.7M Buy
123,472
+27,560
+29% +$2.58M 0.02% 862
2022
Q1
$10.4M Sell
95,912
-24,272
-20% -$2.5M 0.01% 911
2021
Q4
$15.5M Buy
120,184
+2,068
+2% +$254K 0.02% 759
2021
Q3
$14.3M Buy
118,116
+68,996
+140% +$8.4M 0.02% 760
2021
Q2
$5.53M Buy
49,120
+12,988
+36% +$1.37M 0.01% 1228
2021
Q1
$3.45M Buy
36,132
+12,484
+53% +$1.14M 0.01% 1378
2020
Q4
$1.88M Buy
23,648
+6,044
+34% +$438K ﹤0.01% 1659
2020
Q3
$1.09M Sell
17,604
-4,340
-20% -$282K ﹤0.01% 1767
2020
Q2
$1.45M Sell
21,944
-163,436
-88% -$9.79M ﹤0.01% 1631
2020
Q1
$8.79M Buy
185,380
+89,628
+94% +$4.48M 0.02% 712
2019
Q4
$5.25M Buy
95,752
+61,808
+182% +$3.24M 0.01% 1160
2019
Q3
$1.66M Sell
33,944
-155,432
-82% -$7.79M ﹤0.01% 1610
2019
Q2
$9.87M Buy
189,376
+131,956
+230% +$6.65M 0.02% 731
2019
Q1
$2.85M Sell
57,420
-218,368
-79% -$9.83M 0.01% 1247
2018
Q4
$9.98M Buy
275,788
+214,444
+350% +$8.96M 0.02% 639
2018
Q3
$3.13M Buy
61,344
+32,432
+112% +$1.44M ﹤0.01% 1320
2018
Q2
$1.07M Sell
28,912
-10,060
-26% -$384K ﹤0.01% 1724
2018
Q1
$1.47M Sell
38,972
-30,876
-44% -$1.09M ﹤0.01% 1518
2017
Q4
$2.26M Sell
69,848
-1,872
-3% -$59.5K ﹤0.01% 1420
2017
Q3
$2.17M Sell
71,720
-7,800
-10% -$231K 0.01% 1096
2017
Q2
$2.34M Buy
79,520
+23,872
+43% +$652K 0.01% 1101
2017
Q1
$1.41M Sell
55,648
-8,244
-13% -$213K ﹤0.01% 1195
2016
Q4
$1.64M Buy
63,892
+28,880
+82% +$759K 0.01% 1054
2016
Q3
$958K Sell
35,012
-49,124
-58% -$1.35M ﹤0.01% 939
2016
Q2
$2.37M Buy
84,136
+54,348
+182% +$1.4M 0.01% 782
2016
Q1
$704K Sell
29,788
-24,788
-45% -$546K ﹤0.01% 1105
2015
Q4
$1.23M Buy
54,576
+22,496
+70% +$513K ﹤0.01% 1056
2015
Q3
$742K Buy
32,080
+1,212
+4% +$30.4K ﹤0.01% 1166
2015
Q2
$760K Buy
30,868
+25,180
+443% +$629K ﹤0.01% 1204
2015
Q1
$143K Buy
5,688
+1,572
+38% +$37.4K ﹤0.01% 1648
2014
Q4
$95.1K Buy
4,116
+192
+5% +$4.39K ﹤0.01% 1528
2014
Q3
$91.8K Buy
3,924
+2,536
+183% +$59.4K ﹤0.01% 2234
2014
Q2
$32.1K Sell
1,388
-7,980
-85% -$176K ﹤0.01% 2204
2014
Q1
$209K Buy
9,368
+6,936
+285% +$156K ﹤0.01% 1779
2013
Q4
$57.6K Buy
+2,432
New +$52.7K ﹤0.01% 1859

Other funds holding TECH

BNP Paribas Financial Markets's TECH Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its Bio-Techne (TECH) stake by 84% in Q2 2026, buying an estimated $13.4M and bringing the position to 544,961 shares worth $38.5M. The position accounts for 0.01% of the portfolio, ranked #888.

BNP Paribas Financial Markets first reported a position in TECH in Q4 2013 and has held it in 51 quarters since. 560 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • BNP Paribas Financial Markets held 544,961 shares of Bio-Techne worth $38.5M as of Q2 2026.
  • BNP Paribas Financial Markets bought 248,888 Bio-Techne shares in Q2 2026, an estimated $13.4M.
  • Bio-Techne made up 0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #888 holding.
  • BNP Paribas Financial Markets first reported a position in Bio-Techne in Q4 2013 and has held it in 51 quarters since.
  • 560 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.